Rocket Lab's Iridium Deal Faces a New Orbital Obstacle as SpaceX Raises Regulatory Stakes

Rocket Lab's Iridium acquisition faces regulatory complaint and sliding shares, but Q2 revenue surged 62% and backlog grew 137%.

The convergence of a hostile regulatory filing and a sliding share price has put Rocket Lab's proposed acquisition of Iridium Communications under an uncomfortable spotlight, just weeks before shareholders are asked to sign off on the transaction.

SpaceX's complaint to the Federal Communications Commission, lodged against Iridium's conduct during the merger review, knocked Rocket Lab's stock down 4.1 percent on Friday to close at EUR 55.60. The weekly decline now stands at 11 percent, extending a slide that has left the shares roughly 58 percent below their 52-week high of EUR 133.80, reached in late May.

A Deal Structure That Magnifies Every Downtick

What makes the regulatory challenge particularly thorny is the acquisition's mechanics. Each Iridium share converts upon closing into USD 27 in cash plus a variable number of Rocket Lab shares, calculated using a volume-weighted ten-day average price shortly before completion. A falling stock price therefore effectively shrinks the offer value for Iridium shareholders, creating a feedback loop in which regulatory uncertainty and market weakness reinforce one another.

Matthew Turk, SpaceX's director of satellite policy, framed the complaint in stark terms, citing Iridium's "well-documented history of anticompetitive attacks against competitors and American consumers" as a cloud hanging over the proposed combination.

The formal timeline, however, remains intact. Iridium published its definitive proxy statement on August 24, with Rocket Lab filing the accompanying prospectus, setting the shareholder vote for September 24. The Hart-Scott-Rodino antitrust waiting period had already expired on August 12, and Rocket Lab submitted its S-4 registration form to the SEC the following day to register the shares earmarked as purchase consideration, though that registration has not yet become effective.

Insider Sales Draw Scrutiny — and a Standard Explanation

Adding to the narrative noise, five executives sold shares on Thursday totaling USD 5.49 million. Company statements attribute the transactions to tax obligations stemming from vested restricted stock units, with most executed through automated 10b5-1 plans — a routine mechanism rather than a signal of wavering management confidence.

Record Numbers Tell a Different Story

The operational picture stands in sharp contrast to the market's jitters. Rocket Lab reported second-quarter 2026 revenue of USD 234 million on August 10, a 62 percent year-over-year increase, with the backlog swelling 137 percent to USD 2.36 billion. Third-quarter guidance points to revenue between USD 250 million and USD 265 million, a midpoint of USD 257.5 million that reportedly exceeded analyst expectations.

Government contracts have been accumulating as well: a USD 397 million award for the Flatellite space component under the Space Force's SB-AMTI program, a USD 266 million order for suborbital missile-defense launches, and inclusion in the USD 981 million NITE-STAR program. The company also joined the Space Data Network Consortium on August 18, securing two delivery orders worth USD 12 million for the SDN-B optical communications program.

Two days earlier, Rocket Lab confirmed that the first eight of 17 satellite platforms from a USD 143 million deal with MDA Space had reached orbit, where they support Globalstar's direct-to-device communication services.

The launch cadence continues unabated. On August 20 — or August 21 from New Zealand's Launch Complex 1, depending on time zone — the company completed its 93rd Electron mission, deploying the ninth QPS-SAR satellite for Japanese customer iQPS. Nine additional dedicated iQPS launches are already booked through 2030.

Neutron Remains the Wild Card

CEO Peter Beck has urged investors to focus on launch cadence, but the delayed Neutron rocket persists as the primary uncertainty. The earliest first flight has slipped to the fourth quarter of 2026 after repeated postponements, including a first-stage tank crack during testing. CFO Adam Spice noted that a successful test flight could push the company into positive adjusted operating territory the following quarter, though the year-end launch window is tightening.

Technical Signals Point Both Ways

The relative strength index of 34.8 suggests oversold conditions, which could support a short-term bounce. The stock trades roughly 18 percent below its 50-day average, yet remains up 35 percent over twelve months — evidence that the recent weakness reflects a correction rather than a fundamental reassessment. The annualized 30-day volatility of 73 percent underscores how much turbulence investors should expect in the interim.

With the FCC's response pending and the September 24 shareholder vote approaching, the central question is whether Rocket Lab's operational momentum can ultimately outweigh the regulatory friction — and whether the deal's variable-share structure can withstand further downward pressure in the weeks ahead.